Market Cap to Future Revenue Ratio: 111 Inc (YI)

Corporate company logo of 111, Inc. (YI)

A stable technical core and the hiring of IT architects support growth, as visualized by the business's projected P/S in the indicator's chronology on the GURU.Markets chart, where 0.00 reflects the latest metric value for 111, Inc. (YI). The model relies on the digital connectivity between pharmacies and pharma giants, creating an omnichannel gateway to medications and forming a telemedicine ecosystem with high switching costs for partners.

YI - 111 Inc. Price-to-Projected Revenue Ratio over the range 07/04/2022 - 11/13/2026

Metric breakdowns and analytics for 111.com.cn (YI)

- stock quotes and analyst forecast:
Market Chart 111 Inc.|YI - Consensus Target
- company stock exchange capitalization indicators:
Market Value 111, Inc|YI - Enterprise Value
- balance sheet net asset value indicators:
Net Assets per Share 111, Inc.|YI - Company Book Value|Market Capitalization to Net Assets 111.com.cn|YI - Company Total Assets
- issuer credit burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio 111, Inc.|YI - Long-Term Debt to Capital|Short-Term Debt to Capital 111 Inc.|YI - Company Debts|Debt to Net Assets Ratio 111, Inc.|YI - Company Long-Term Debt|Company Current Liabilities 111, Inc.|Quick Ratio 111.com.cn
- earnings and market ratios statistics:
YI - Net Profit|Future Profit 111, Inc.|YI - Price to Earnings Ratio|Projected Price to Earnings Ratio 111 Inc.|YI - PEG Multiple|EV/EBITDA Multiple 111, Inc|YI - Operating profit EBITDA|Net earnings per share for the last 12 months 111, Inc.|YI - Earnings per share for the trailing year|Quarterly EPS earnings growth 111.com.cn|YI - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year 111, Inc.
- sales revenue and business income indicators:
YI - Company Sales Volume|Projected Sales Volume 111 Inc.|YI - Market Cap to Revenue|Forward Price-to-Revenue Multiple 111, Inc.
Summary company analytics:YI, 111 Inc
Core merchandise of 111.com.cn

Forward P/S measures the ratio of a company's current market value to its expected revenue, allowing for an assessment of whether an asset is overvalued or undervalued relative to its potential. Amid strict government price regulations and low margins at 111, Inc. (YI), the forward P/S valuation helps determine the extent to which market optimism is justified against a backdrop of high logistics costs and competitive pressure.

Who 111, Inc. competes with

Market Cap to Expected Sales Ratio CVS|MCK - Forward Price-to-Revenue Multiple|COR (AmerisourceBergen) - Market Cap to Future Revenue Ratio|CAH - Forward P/S Multiple|Henry Schein, Inc. - Market Cap to Expected Sales Ratio|PBH (prestigebrands.com) - Price-to-Projected Revenue Ratio|Future Price to Revenue Wellgistics Health, Inc. WGRX|Forward P/S Multiple China Jo-Jo Drugstores, Inc.|Universe Pharmacy (UPC) - Forward Price to Sales|Forward P/S Multiple biodexapharma.com (BDRX)|Forward P/S Multiple HKPD (Hong Kong Pharma Digital Limited)|usbimi.com - Price-to-Projected Revenue Ratio|Forward Price to Sales Jiuzhou 360 (CJJD)|WBA: Price-to-Projected Revenue Ratio